© Copyright Nostre Net
The Arterial
Blood Collection Market is projected to reach USD 1924.34 million by 2030
at 10.2% CAGR during the forecast period 2022-2030. The rise in diagnostic
procedures is shaping the demand for the arterial blood collection devices
market positively. Reports that evaluate the medical device industry have been
made accessible by Market Research Future, which creates reports on several industry
verticals that review the market development and prospects. The market is
poised to achieve a CAGR of 9.1% while amassing income worth USD 1,624.6
million by the conclusion of the forecast in 2023.
The expansion of the diagnostic sector is expected to create
momentum for the expansion of the market. Moreover, the increased detection
rate of chronic ailments is expected to encourage the progress of the arterial
blood collection devices market. The escalated investment being dedicated to
research and development in the arterial blood collection devices market is
estimated to benefit long-term growth.
Segmental Analysis
The segmental evaluation of the arterial blood collection
devices market is carried out on the basis of type, application, end user, and
region. Based on type, the market for arterial blood collection devices is
segmented into microfluidic system, lancet, needles, blood collection tubes,
vacuum blood collection system, and other devices. By application, the arterial
blood collection market is segmented into intraoperative blood salvage and
arterial blood gas sampling. The arterial blood gas sampling is further
sub-segmented into acid base status monitoring and diagnosis of disease. The
end-user based segmentation of the arterial blood collection devices market
comprises of hospitals & clinics, blood banks, laboratories, and others.
Based on the regions, the arterial blood collection devices market comprises of
Europe, the Americas, APAC, and the Middle East & Africa.
Detailed Regional Analysis
The regional assessment of the arterial blood collection
devices market includes regions such as Europe, the Americas, APAC, and the
Middle East & Africa. The Americas is responsible for a substantial market
share in 2016, as a result of growing prevalence of chronic diseases,
increasing emphasis on safe blood transfusion processes the concentration of
major market players producing blood collection devices, and widespread demand
for diagnostic services.The European region is the second principal
market and holds a significant share in the arterial blood collection devices
market. The availability of funds from the government for research and
development is anticipated to contribute to the development of the market. The
increased demand for diagnostic services in the Asia Pacific region is a
significant factor for market development. Increasing awareness about the use
of sterile blood collection devices and an escalating number of surgical
procedures are driving the market in the Asia Pacific region.The Middle
East and African region are anticipated to display steady growth in this market
owing to the growing prevalence of transmissible transfusion infections and the
demand for medical devices for diagnostics. The government has also commenced
awareness programs for safe blood transfusion procedure, which is additionally
improving the health conditions in the underdeveloped regions of Africa.
Competitive Analysis
Amplified investment in the market is likely to motivate the
positive changes in the market in the forecast period. The decrease in trade
restrictions is anticipated to create favorable opportunities for development
in the forecast period. The presence of favorable trade policies is anticipated
to improve the growth of the market in the impending period. Strong insights
into the market’s condition is motivating the expansion of the forecast period.
The offering in the market has also diversified considerably ensuring
availability of better-quality products in the market. The emergence of
specialization in production has also increasingly improved the growth
trajectory of the market. The efficiencies achieved in the allocation of
resources is expected to encourage the development of the market in the
approaching period. Moreover, increased cost efficiencies are projected to
positively impact the progress of the market in the coming years.
The chief contenders in the artificial blood collection
devices market are Terumo Medical Corporation (U.S), Bio-Rad Laboratories, Inc.
(U.S), Becton, Dickinson and Company (U.S), Qiagen (Netherlands), NIPRO Medical
Corporation (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher
Scientific, Inc. (U.S) and others.
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The
importance of beauty and personal appearance currently is at an all-time high
as compared to earlier times due to the development of social media
proliferation, thus boosting the Asia Pacific Aesthetics Market. Reportscreated by MRFR detail the developments in the industry that can be
expected in the market through the forecast period. The Asia
Pacific Aesthetics market size is projected to reach USD 4.3 Billion by
2032 at 9.9% CAGR during the forecast period 2023-2032.
The breakthroughs in non-invasive
procedures due to advancements in technology are estimated to further influence
the Asia Pacific Aesthetics Market
expansion. Moreover, the heightened level of affluence in the end-user base is
estimated to contribute to the Asia Pacific Aesthetics Market share in the
upcoming period.
Prominent Companies
ZELTIQ Aesthetics Inc. (U.S.), Galderma
S.A. (Switzerland), Alma Lasers (Israel), Lumenis (Israel), PhotoMedex,
Inc. (U.S.), Cutera (U.S.), Johnson
& Johnson Services, Inc. (U.S.), Solta Medical, Inc. (Canada), Syneron
Medical Ltd. (U.S.), Mentor Worldwide LLC (U.S), Merz Pharma (Germany), Integra
Lifesciences (U.S.), Cynosure Inc. (U.S.), ALLERGAN (Ireland), Sanofi (France),
are some of the leading companies in the Asia Pacific aesthetics market.
Market Segmentation
The Asia
Pacific aesthetics market has been segmented on the basis of procedures,
products, application, and end-user.
The
various procedures in the market are surgical aesthetic procedures and
nonsurgical aesthetic procedures. The surgical aesthetic procedures are
categorized into liposuction, breast augmentation, tummy tuck, eyelid surgery,
breast lift, dermabrasion, and others. On the other hand, the nonsurgical
aesthetic procedures are split into the segments of botulinum toxin, hyaluronic acid, hair removal, photorejuvenation (IPL),
chemical peel, microdermabrasion, and others.
Product-wise,
the market caters to laser and energy-based devices, skin tightening and body
contouring devices, aesthetic implants, and others. The types of skin
tightening and body contouring devices are liposuction devices, cellulite
reduction devices, cryolipolysis technology, anti-aging device, and others. The
aesthetic implants are fragmented into dental implants, breast implants, buttock augmentation,
transdermal implants, and others.
The
various applications are facial & body contouring, facial & skin
rejuvenation, breast enhancement, scar treatment, reconstructive surgery,
tattoo removal, malignant ascites, vaginal
rejuvenation, and so on.
Depending
on end-user, the market can be segmented based on hospitals & clinics,
dermatology clinics, cosmetic centers, and others.
Detailed
Regional Analysis
The
regional scrutiny of the Asia Pacific Aesthetics Market Insights consists of North America, Europe, Africa,
and the Middle East. The North American region’s Asia Pacific Aesthetics Market
is estimated to emerge as the principal regional market in the overall Americas
region. The aesthetic industry growth in the North American region is the
outcome of the speedy development in beauty treatments and various anti-aging
cosmetic operations. The Mexican aesthetic devices market in the region has
been bolstered by the mounting interest in cosmetic techniques, improving
healthcare infrastructure, intensifying problem of skin illnesses, and the
increasing number of accomplished board-certified cosmetic doctors. The
regional market of Europe is promoted to be the next highest gainer in the
worldwide market in the future, supported by the collective support given by
the government and the great population of elderly patients who need
improvement in physical form. The substantial healthcare expenditure is another
development-inducing influence in the regional market. The APAC regional market
is estimated to be driven due to the exploding patient population, swift
innovations in technology, and the profusion of lucrative prospects for global
companies in the region. The UAE aesthetic devices market in the Middle Eastern
region is mounting at an encouraging rate, because of the rising surgeries
counting facial fat grafting, breast enlargement, liposuction, and more. The
need for innovative devices and tools to ensure safer and more effective
procedures are projected to guide the Asia Pacific Aesthetics Market in the
region.
Competitive
Analysis
The
funding scenario in the market is estimated to be optimistic and conducive to
the development of the stakeholders in the market. The government policies in
several regions are very conducive to the development of the market in the
upcoming period. The advancement of production technology and processes is
estimated to augment the global market. The establishment of clear long-term
objectives by market titans is estimated to set the tone for the continuing
expansion of the market. The identification of areas for sustainable
enhancement in the supply chain is estimated to further fortify the market. The
advancement of the market is spurred by the initiatives of the leaders in the
global market, who are dedicating resources to the development of the overall
market. The scale of innovation being observed in the market is another reason
that is adding to the advancement of the global market in the future. The
detrimental impact on the environment by the business practices is estimated to
be a key component in the future growth strategies of the market.
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Market Research Future (MRFR) has published
a research report about the global neurovascular
devices market size to touch over USD 4.2 Billion by 2030. MRFR also
anticipates the global market’s growth to be at a rate of 5.7% during the
review period 2022 to 2030. This report talks about the market scenario and
future prospects regarding growth. In this report, the global neurovascular
devices market has been segmented on the basis of end-user, product,
therapeutic application, and lastly region.
Problems related to the nervous system are
serious. They cannot be seen easily, and their therapies usually lie in
surgeries where patients and doctors need to decide which surgeries are more
invasive and which are less invasive. Neurovascular devices are necessary for
treating neurovascular diseases. These devices have been developed due to
demand for minimally invasive procedures. There has never been a dearth of
neurovascular patients. Therefore, the global neurovascular devices market has
huge scope for growth. Factors contributing to the growth of this market
include favorable reimbursement policies, and ongoing product development &
commercialization.
On the basis of the end-users, this market
has been segmented into ambulatory surgical units and hospitals & clinics.
Ambulatory surgical units work for ambulatory surgery centers (ASC) that are
also known as outpatient surgery centers, same-day surgery centers, or
surgicenters. Ambulatory surgical units perform surgical procedures not
requiring an overnight hospital stay. Such surgery is commonly less complicated
than those required hospitalization.
Key Players
The key players in the global neurovascular
devices market include Abbott Laboratories (USA), Blockade Medical LLC.
(France), Delaware Corporation (USA), Evasc (Canada), Gynesonics (USA),
Johnson & Johnson Services, Inc. (the USA), Medikit Co., Ltd. (Japan),
Medtronic (USA), Merit Medical Systems Inc. (USA), MicroPort Scientific
Corporation (China), Neuravi (Israel), OxfordEndovascular (UK), Penumbra, Inc.
(USA), Rapid Medical (Israel), Sensome (France), Secant Group LLC (USA),
Stryker (USA), Terumo Corporation (Japan), and W. L. Gore & Associates,
Inc. (USA).
Segmentation:
The product-based segmentation segments the
Neurovascular
Devicesmarket insights into aneurysm coiling & embolization
devices, cerebral balloon angioplasty & stenting systems, neurovascular catheters, neuro thrombectomy devices,
and a support device. The aneurysm coiling & embolization devices segment
has been sub-segmented into embolic coils, flow diversion devices, and liquid
embolic. Embolic coils block blood flow into an aneurysm (weak area of an
artery). The embolic protection systems have been segmented into balloon
occlusion devices and distal filter devices. Cerebral angioplasty is a
procedure useful for opening the partially blocked carotid and vertebral
arteries in the neck. They can also do the same for blood vessels within the
brain. It has been segmented into is sub-segmented into carotid artery stents
and embolic protection systems. Stenting system indicates an improvement of
coronary luminal diameter in patients with symptomatic ischemic heart disease.
Neurothrombectomy devices are used for treating acute ischemic strokes. They
have been sub-segmented into aspiration devices, retrieval systems, and suction
devices. Based on therapeutic application, the market has been segmented into
the hemorrhagic stroke and ischemic strokes. A hemorrhagic stroke can be
defined as either a brain aneurysm burst or a weakened blood vessel leak. The
different types of ischemic strokes occur when the body is deprived of oxygen
or any other important nutrients.
The regional segmentation of the global
neurovascular devices market comprises of The Americas (North America &
South America), Europe, Asia Pacific, and Middle East & Africa (MEA)
region. The Americas dominate the global neurovascular devices market due to a
large number of patients suffering from neurovascular diseases like
arteriovenous malformations (AVMs) and brain aneurysm. Due to technological
advancement, high disposable income, and the availability of better medical
facilities, North America is the bigger market than South America. Moreover,
increasing healthcare expenditure, government aid to researches in the field of
medical sciences and the presence of the key players in North America boosts
the growth of the market in North America. Majority key players in this region
are based in the United States of America (USA).
Europe holds the second largest share in
global neurovascular devices market. Increasing prevalence of the neurovascular
diseases and the presence of a well-developed healthcare sector are the major
factors that drive the market growth in this region. Due to reasons same as The
Americas, Western Europe market is bigger than Eastern Europe. In Europe, most
of the key players in this market are based in France and the United Kingdom
(UK).
The Asia Pacific region is the fastest
growing market for the market due to continuously developing economies like
China and India, increasing demands for minimally invasive surgeries by the
growing geriatric population, and the presence of a huge patient population.
Asia Pacific region is yet to achieve the infrastructure development and
technological advancement as par the level of North America and Europe, and
there are few countries in this region that are technologically advanced. In
the Asia Pacific region, the biggest markets are Australia, China, India,
Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is a
small market due to political instability in most countries due to movements
like Arab Spring. Lack of technology and less investment in healthcare due to
healthcare not being considered a priority by governments in this region are
the reasons for a small market. The biggest markets in this region are Kuwait,
Oman, Saudi Arabia, Qatar, and United Arab Emirates (UAE), followed by rest of
MEA region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Surgical
Robots Market Overview and analysis By Product Type, By Application, By
Control Mechanism, By End-User and Region—Forecast till 2030
The Global Surgical Robots Market is growing with the rapid
pace mainly due to the burgeoning Healthcare Industry. According to a
recent study report published by the Market Research Future, The surgical
robots market size was valued at USD 4.21 billion in 2021 and is projected to
grow from USD 5.05 Billion in 2022 to USD 21.41 billion by 2030, exhibiting a
compound annual growth rate (CAGR) of 5.8% during the forecast period (2022 -
2030).
Advancements in technology have empowered surgeons to
remotely operate robots and perform surgery. Surgeons can perform a surgical
procedure in emergency situations through telesurgery, with the aid of an
imaging device. There are many advantages of robotic surgery over
traditional open surgery like more accuracy, less pain, small insertions and
many more. Increasing automation in healthcare sector and increasing
demand for the minimally-invasive surgeries and more advances robotics has
led to growth of this market across the globe. Beside this increasing incident
of cancer, different neurological disorders and many more diseases has provided
fuel for the growth of the market. Additionally, advancements in technology
over the fast few years have been directed towards reducing costs of products.
This has led to increasing applications of these robots for various tasks.
While high cost of surgical robots, risks associated with
the robotic surgeries and the scepticism toward technology may hamper the
growth of the market. Adversely, the development of Surgical robots with high
artificial intelligence technology is driving the Surgical robots market.
Surgical Robots Global Market – Segments
The Surgical Robots Market can be segmented in to 4 key
dynamics for the convenience of the report and enhanced understanding;
Segmentation By Control Mechanism : Comprises Direct
Telemanipulator and Computer Control.
Segmentation By Robotic Surgery Approach : Comprises Supervisor-Controlled
Robotic Surgical System, Shared Control Robotic Surgical Systems, Telesurgery
Systems, Robotic Radiosurgery Systems.
Segmentation By Application : Comprises General Surgery, Cardiac
Surgery, Gynecologic Surgery, Colorectal Surgery, Urologic Surgery, Head
and Neck Surgery and other.
Segmentation By Regions : Comprises
Geographical regions - North America, Europe, APAC and Rest of the World.
Surgical Robots Global Market – Competitive
Analysis
Characterized by the presence of well-established players; Surgical
Robots market research report appears to be highly competitive. Well
established players incorporate acquisition, collaboration, partnership,
expansion, and product launch in order to gain competitive advantage in this
market and to maintain their market position. Vendors are focusing on improving
their market performance and are expanding by acquiring promising companies in
the fast-growing markets. Marketers employ a continuous improvement strategy
to analyze and update the software, implementing improvements
and launching new technologies to meet the changing needs of consumer.
These manufactures develop a well-established infrastructure that allows
seamless implementation of advanced technologies. They strive to develop
unravel design and adept technology Heavy investments are transpired in R&D
sector from the major players which is in turn helping the market to
grow.
In view of growth and immense revenue generation
opportunities potential that market is currently demonstrating is in turn
attracting several new players to enter the market. However, those new entrants
find it challenging to survive in the market with the introduction of new
technologies.
Surgical Robots Global Market – Regional Analysis
On regional basis, America has the largest market for
surgical robots. Availability of finance, well developed healthcare sector with
continuous increasing prevalence of number of diseases are the major driving
factor for America surgical robots market. North America is the major
contributor for the Americas surgical robots market. In 2016, North America
surgical robots market was USD 1,655.8 million. Europe has second leading
market which is followed by Asia Pacific region. Increasing prevalence of diseases
like cancer and many neurological disorder in Europe has help to grow this
market. Asia Pacific region is showing slow growth for surgical robot market.
Asia Pacific surgical robots market is expected to grow at a CAGR of 23.36 %
forecast period from 2017-2023
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Malaria is a life-threatening disease that is transmitted
through the bite of infected anopheles mosquitos. The infected mosquitos
transmit the plasmodium parasite into the bloodstream of human body upon being
bitten. As the parasite enters the human body, it travels around the body to
affect the liver and matures with time. Upon attaining maturity, the parasite
enters the bloodstream to infect the red blood cells in the body. This causes
individuals suffering from malaria to frequently experience headache, vomiting,
fever, and weakness.
The Africa
malaria diagnosis & treatment market Research report is projected to
reach USD 2,467.6 Million by 2030 at 6.9% CAGR during the forecast period
2022-2030.It is reported in a study released by Market Research Future (MRFR),
that the market is positively influenced by a number of factors. A major factor
influencing this growth is the increasing advancements in technology related to
diagnostic tools and the proliferating demand for such treatments in
malaria-endemic countries. Other factors driving the market growth are rising
support from the government in terms of investment funds and an increase in the
collaboration between the research centers and the industry. Malaria diagnostic
tests play a significant role in identifying malarial cases, which thereby
boosts the growth of the overall malaria diagnostic market.
However, the lack of precise monitoring standards at
developing nations, acts as a major factor constraining the market. The lack of
awareness among emerging nations and work regulatory framework is of particular
concern for both manufacturers and healthcare providers.
Market Segmentation
The global malaria diagnostics market segmentation is done
as per technology and end-user.
By technology, the market is divided into microscopy,
molecular diagnostic tests, and rapid diagnostic tests. Furthermore, the
molecular diagnostic test is narrowed down into real-time polymerase chain
reaction (RT-PCR) and polymerase chain reaction (PCR).
By end-users, the market comprises of clinics, hospitals,
community healthcare, and others.
Regional Analysis
Geographically, the global malaria diagnostic market covers
regions such as North America, European, Asia Pacific, and Middle East &
Africa.
The North American region holds the largest share of the
malaria diagnostic market and leads the global standings. The region is further
expected to garner the largest market share during the forecast period 2018 and
2023. The market is slated for growth due to the rise in awareness, advancing
medical technologies, favorable compensation setting for various surgical
methods and procedures, medical tourism, and expanding growth of the healthcare
sector.
Competitive Landscape
The global malaria
diagnostics market Trends comprises of a number of key and prominent
players, including Leica Microsystems GmbH, Premier Medical Corporation Pvt.
Ltd, Access Bio. Inc., Beckman Coulter Inc., bioMérieux, Nikon Corporation,
Abbott Laboratories, Olympus Corporation, Sysmex Partec GmbH, Siemens
Healthineers, and Bio-Rad Laboratories Inc.
March 28th, 2019, Global Health Innovative
Technology Fund announced a total of 2.86 Billion Yen to aid 10 partnerships to
research and develop new lifesaving drugs, diagnosis, and vaccines for
disorders like Vaccines for Leishmaniasis and Malaria, Schistosomiasis,
Malaria, Tuberculosis, Dengue, and Diagnostics.
Jan 2nd, 2019, ERADA Technology Alliance LTD, one
of the leaders of innovative, rapid diagnostic solutions for early stage
detection of infectious diseases, announced the launch of one of the world’s
first diagnostic saliva test for malaria.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Ultrasound Devices Market Overview Analysis By Portability, By Display, By
Application, By Technology, By End-user Forecast till 2030. Ultrasound Devices Market Size was valued at USD 10.8 billion in
2022. The ultrasound devices market industry is projected to grow from USD 11.2
Billion in 2023 to USD 14.2 billion by 2030, exhibiting a compound annual
growth rate (CAGR) of 4.10% during the forecast period (2023 - 2030).The report
elaborates on the major drivers and restraints for the global ultrasound
devices market in detail by analyzing their impact on the market’s trajectory
over the forecast period.
The growing
demand for ultrasound devices for diagnostic purposes is likely to be the major
driver for the global ultrasound devices market over the forecast period.
Ultrasound devices work by sending out high-frequency sound waves that provide
a picture of the targeted area based on the response of various bodily tissues
to the sound waves. Since different tissues react differently to the same sound
waves, the technique has become popular in the healthcare sector. The lack of
invasion in the use of ultrasound equipment manufacturers has also become a key
plus point for the market due to the growing obsession with minimally invasive
and noninvasive medical procedures. Therapeutic applications of ultrasound
include targeting a specific patch of tissue for stimulation or removal by bombarding
it with high-frequency sound waves. This application is also likely to remain a
key factor for the global ultrasound devices market’s growth over the forecast
period.
Competitive Analysis:
Leading players
in the global ultrasound devices market include Siemens AG, GE, Hitachi Ltd.,
Shimadzu Corporation, Analogic Corporation, Mindray Medical International Ltd.,
Toshiba Corporation, Samsung Electronics Co. Ltd., and Koninklijke Philips NV.
Regional Analysis:
The Americas is
likely to be the major regional for ultrasound
devices market research report over the forecast period due to the
widespread adoption of advanced ultrasound technology in the region and the
growing demand for advanced diagnostic modalities and devices. Europe is also
likely to remain a major regional market for ultrasound devices over the
forecast period due to the growing healthcare expenditure in the region. Asia
Pacific is expected to exhibit the fastest growth over the forecast period due
to the growing demand for advanced medical facilities and devices and the
increasing investment in hospitals and medical technology.
Segmentation
Analysis:
By display, color devices accounted for a
largest market share in 2017 compared to its counterpart, black/white
ultrasound devices. The former can touch a size of USD 7,509.12 million by
2026, while the latter is likely to show prominent growth by the end of the
forecast period.
By application, radiology/general imaging is
likely to register highest CAGR during the assessment and likely to dominate
the market by 2026. It accounted for the largest market share in 2017 due to
its vast medical applications. The rising geriatric populace and incidence of
various cancers can spur the segment growth. On the other hand, cardiology is also showing significant growth by 2026.
By technology, diagnostic accounted for the
largest market share in 2017 due to the use of 2D ultrasound in women’s health.
It is likely to show CAGR over the assessment period and hold significant
market share by 2026 due to the continuous advances in imaging and
reimbursement schemes for these procedures. On the flip side, therapeutic
ultrasound is expected to hold second position by 2026.
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Middle-East and Africa Stroke Diagnosis and
Treatment Market was estimated around US$ 186.4 million in 2015 and is expected
to reach US$ 289.7 million by 2022 at a CAGR of 6.5% by 2030. There are several
factors which are prohibiting the growth of the market such as high cost of
treatment and drugs, lack of early treatment, lack of awareness and healthcare
facilities particularly in African countries etc.
The Middle-East and Africa Stroke
Diagnosis and Treatment Market Trends has been evaluated as moderately
growing market and it is expected that the market will continue to grow at same
pace in the near future. Stroke affects blood supply to brain. Blood
vessel that carries oxygen and nutrients to the brain is either blocked by a
clot or bursts is the cause of stroke. Due to this brain cells starting to die.
Ischemic strokes occur due to narrowing or blocking of arteries to the brain
while Hemorrhagic strokes are caused by blood vessels in and around the brain
bursting or leaking. There are some symptoms like problem in speaking,
inability to move etc.
Stroke Diagnosis and Treatment Market
Players:
There are plenty of large and small market
players which operates in Middle East and Africa market as well as all over the
globe. King Faisal Specialist Hospital and Research Centre (Saudi Arabia),
Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar),
American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), Abbott (US),
Johnson & Johnson Services, Inc. (US), GE Healthcare (UK), Koninklijke
Philips N.V. (Netherlands), Hitachi, Ltd. (Japan)
Regional Analysis:
Considering the Middle-East and Africa
Stroke Diagnosis and Treatment Market scenario, UAE region is believed to be
the largest market for Middle-East and Africa Stroke Diagnosis and Treatment.
Moreover Saudi Arabia market is also growing and second largest market for
Stroke Diagnosis and Treatment. On the other hand, Egypt market is expected to
grow at the steady pace in the Middle-East and Africa Stroke Diagnosis and
Treatment during the forecasted period. Rest of the Middle East and Africa
region is likely to have a limited but steady growth in the market.
Segmentation:
Middle-East and Africa Stroke
Diagnosis and Treatment market Report has been segmented on the basis of
type which comprise Ischemic strokes, Hemorrhagic strokes, and others. On
the basis of diagnosis the market is segmented into Blood tests, Computerized
tomography scan, Magnetic resonance imaging, Carotid ultrasound, cerebral
angiogram, Echocardiogram, and Others. On the basis of stroke
treatment it is segmented into
cerebral thrombosis, Surgical clipping, endovascular embolization, Angioplasty
and stents, Surgical AVM removal, Intracranial bypass, Stereotactic radiosurgery,
and others.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Lancet
Market overview and analysis by Type, End User and Region - Forecast till
2027. Lancets are small medical equipment with double-edged blade or needle and
are used for capillary blood sampling. As per the report that has been recently
published by Market Research Future (MRFR), Lancet Market Size was valued at
USD 1.2 billion in 2022 and is projected to grow from USD 1.32 billion in 2023
to USD 2.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of
10.50% during the forecast period (2023 - 2030).
Market Drivers and Restraints:
Increasing demand for blood sampling devices owing to the
increasing prevalence of various contagious and non-contagious diseases is
majorly driving the global lancet market. The need for discarding a lancet
after a single use for hygiene purpose is one of the major factors that are
generating high demand for lancets in the global market. Increasing use of
lancets by individuals suffering from endocrine-related complications,
cardiovascular diseases and other disorders is positively impacting the growth
of the global lancets market.
Lancets are commonly used by diabetic patients for regular
blood sampling. Increasing prevalence of diabetes is resulting in the rise in
demand for blood lancets, leading to the expansion of global lancet market. The
demand and supply of multiple types of lancets such as surgical lancets, blood
lancets and vaccination lancets have increased significantly in the past few
years, which in turn is fueling the expansion of the global lancet
market.
However, risk associated with blood transfusion, poor health
care facilities and lack of awareness among the population of underdeveloped
regions are likely to act as restraints on the growth of the global lancets
market.
Market Segmentation:
The global lancet market has been segmented on the basis of
types and end-users.
Based on types, the global lancet market is segmented into
personal, safety and others. The safety lancets segment is anticipated to
expand significantly during the forecast period owing to the need for immediate
disposal of these lancets after a single use.
Based on end -users, the lancet market is segmented into
hospitals and clinics, diagnostic centers and pathology laboratories, home
diagnostics, and others.
Regional Analysis:
Geographically, the global lancet
market research report is segmented into four major regions such as North
America, Europe, Asia Pacific and the Middle East and Africa. Among these, the
North America region is dominating the global lancet market owing to the high
demand for different types of lancets in the well-developed healthcare sector
and increasing prevalence of diabetes in this region.
The Europe region stands second in the global lancet market
with respect to the market size. The improvement in regulations over medical
devices and increasing inclination towards home healthcare is driving the
lancet market in this region.
The Asia Pacific region is anticipated to project
significant growth in the lancet market during the forecast period owing to the
increasing incidences of contagious and non-contagious diseases in this
region.
Lack of awareness and poor primary health care facilities in
the underdeveloped areas of the Middle East and Asia are resulting in the slow
growth of lancet market in this region.
Key Players:
The major players profiled by MRFR in the report on the
global lancet market are F. Hoffmann-La Roche AG, Becton, Dickinson and
Company, Greiner Bio One International GmbH, Improve Medical Technology Co.
Ltd, Terumo Medical Corporation, Bayer Cropscience Limited, HTL-STREFA S.A,
Sarstedt AG & Co and Others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
The surge in cancer diagnoses globally is
estimated to fuel the progress of the Cancer Diagnostics Market. The market's
report is efficiently analyzed as per MRFR, which provides outlooks for the
global Cancer
Diagnostics Market Report was valued at USD 160.2 billion in 2021 and is
projected to grow from USD 170.9 billion in 2022 to USD 269.1 billion by 2030,
exhibiting a compound annual growth rate (CAGR) of 6.70% during the forecast
period (2022 - 2030).
The advancement in diagnostic markers and
science has led to the development of the cancer diagnostics market in the forthcoming period. The improvement in
reimbursement policies is estimated to support the expansion of the tissue
diagnostics market in the impending period.
Segmental
Analysis
The
segmental overview of the cancer diagnostics market is carried out on the basis
of type, application, end user and regions. The cancer diagnostics market's
application segment comprises breast cancer, colorectal cancer, melanoma cancer, lung
cancer, prostate cancer, and liver cancer. The cancer diagnostics market's end
user segment comprises hospitals and clinics, diagnostic centers, and research
institutes. The region segment of the cancer diagnostics market comprises of
the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The type
segment of the cancer diagnostics market comprises of biomarkers testing,
biopsy, imaging testing, and in-vitro diagnostic testing.
Regional
Overview
The regional examination of the
cancer diagnostics market comprises of the Americas, the Middle East, Africa,
Europe, and the Asia Pacific. The Americas cancer diagnostics market Statisticsgoverned the global market due to the
mounting elderly inhabitants, the firm healthcare sector, and growing
healthcare spending. The European cancer diagnostics market held the second
major part of the cancer diagnostics market. The growing awareness about
cancer, technological developments in the region, and mounting demand for
efficient handling and diagnostics for cancer is anticipated to drive the
development of the regional cancer diagnostics market. Germany directed the
largest portion in the European market for cancer diagnostics. The Asia-Pacific
cancer diagnostics market is anticipated to register the fastest development in
the cancer diagnostics market throughout the forecast period owing to the
incidence of a large patient collection and snowballing government proposals
for the growth of the healthcare sector in the region. Nations in Asia-Pacific
are implementing advanced treatment options, which in turn powers the cancer
diagnostics market growth in this region.
The market is projected to witness a period
of turbulence with the impact of the pandemic on the workforce and the economy
as a whole. The collaborative efforts of the market contenders are expected to
broaden the horizons for development in the foreseeable future. The measures
being undertaken to ensure seamless functioning of the market is estimated to
lay off in the long run. The investment towards cutting-edge technology is
anticipated to take a sharp surge with amplified funding accessibility. The formation
of strong trade relations among several regions is forecasted to have a
beneficial effect on growth. The focus on the client's needs is estimated to be
more important than before as changes in living standards can have a notable
bearing on the popularity of certain market trends. The contenders in the
market are likely to see aggressive competition in the coming years. The
reimagined market structure is predicted to rely on a combination of robust
online selling capabilities and a capable supply chain.
The distinguished companies in the cancer
diagnostic market are Arquer Diagnostics Ltd, Illumina, Inc., Becton, Dickinson
and Company (BD), BioMark Diagnostics Inc., Biotheranostics, Exact Sciences
Corporation, Cancer Diagnostics, Inc., Agilent Technologies, Inc., Thermo
Fisher Scientific, Inc., GE Healthcare, QIAGEN N.V., Roche Diagnostics, Siemens
Healthcare, Abbott Laboratories, Inc., and Koninklijke Philips N.V., Inc.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The global dental CAM milling market is highly modest.
Market Research Future Reports published its latest reports on global The Dental
CAM Milling Machine Market size is expected to reach USD 1,987.29 Million
by 2030 at 9.30% CAGR during the forecast period 2022-2030. The market is
at a position to sustain its intense competition and introducing many
opportunities in the future timeline. To be at the same pace of growth and
market position, the key players are continually executing various strategies
such as mergers, acquisitions, partnerships, etc. to make the market rise high
and garner tremendous valuation in the coming years.
Global Dental CAM Milling Market: Drivers & Trends
The main factors responsible for the growth of global dental
cam milling machine market are accounted as high adoption of CAD/CAM systems in
the dentistry, that resulted in the increased usage of CAM milling machines,
growing ability to process different dental materials such as zirconia,
acrylic, wax, metal and others with high accuracy and precision. With that,
more factors supported behind the growth of the market, which is accounted to
be the growth of dental service organizations, development of new dental
restorative materials, patient-customized treatment approach, and increasing
cosmetic dentistry treatments.
Furthermore, the rise of numerous dental disorder cases,
increase of elderly population and surge in dental disorders that lead to tooth
deformations and technological innovation in dentistry are the factors that are
catering to the global dental milling machines market substantially. Besides,
more factors such as a surge in preference for corrective dental surgeries is
expected to augment the global dental milling machines market in the next few
years.
Dental CAM Milling Market Segmentation
According to the reports published by MRFR, the global dental
milling machines market insights has been segmented by type, application,
and end-user.
By the mode of type, the market includes ilab scale milling
machines and office scale milling machines.
By the node of application, the market includes crowns,
dentures, bridges, veneers, and inlays / onlays.
By the mode of end-user, the market has been categorized as
a dental laboratory, dental clinic, and research/academic institutes.
Regional Outlook
On a geographical note, the global dental milling machines
market has covered the main regions of Europe, North America, Asia Pacific, and
the Middle East & Africa.
Among these, Europe has recorded and garnered the largest
share of the market owing to the early adoption of novel technologies in this
region. The newly advanced technology and dental hygiene witnessed in the
region are likely to boost the extension of the dental CAM milling machine
market in the next couple of years.
Whereas, North America is at the second position of the
global dental CAM milling machine market during the forecast period. Factors
such as the rising burden of dental disorders have projected to lead the growth
of the market in the region. Also, the emphasis of the healthcare providers
towards the progress of dental care services is probable to favor the growth of
the dental CAM milling machine market in the region at a rapid pace.
Lastly, the Asia Pacific region is a highly lucrative market
and is forecasted to record the highest CAGR over the forecasted period. The
rising population of older adults in countries of Asia Pacific is likely to
fuel demand for dental CAM milling machine along with the variations in the
food culture and lifestyle have been prone to boost the growth of the market
across the review period.
Key Players
Market Research Future Reports have sorted some of the key
players in this market are, they are Axsys Incorporated, B&D Dental
Technologies, DATRON AG, Dentsply Sirona, KaVo Dental GmbH, Planmeca OY,
Straumann, and Yenadent Ltd.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.